The US Food and Drug Administration gave approval to Dr Reddy’s Laboratories and Fresenius Kabi Oncology, both listed Indian pharmaceutical companies, to market cancer drug letrozole or the generic version of Femara in the US. Novartis owns the patent for Femara, a drug used to treat breast cancer in post-menopausal women, which earned US-market sales of $682 million or Rs 3,100 crore in 2010.
indiabusinessview - Business News, Financial News, Analysis, Commentary, Views, Opinion
indiabusinessview (https://indiabusinessview.com/tag/fresenius_kabi_oncology/)